NB200111B
p14ARF/CDKN2A Antibody, Biotin, Novus Biologicals™
Manufacturer: Novus Biologicals
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NB200111B-Each-of-1 | In Stock | ₹ 53,218.32 |
NB200111B - Each of 1
In Stock
Quantity
1
Base Price: ₹ 53,218.32
GST (18%): ₹ 9,579.298
Total Price: ₹ 62,797.618
Antigen
p14ARF/CDKN2A
Classification
Polyclonal
Dilution
Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, KnockDown Validated
Gene Accession No.
Q8N726
Gene Symbols
CDKN2A
Immunogen
A synthetic peptide made to a portion of human p14ARF (between residues 50-150). [Swiss-Prot# Q8N726]
Quantity
0.1 mL
Research Discipline
ABC Transporters, Cancer, Cell Biology, Cell Cycle and Replication, Chromatin Research, DNA Repair, Hypoxia, MAP Kinase Signaling, Neuroscience, Transcription Factors and Regulators, Tumor Suppressors
Gene ID (Entrez)
1029
Target Species
Human, Mouse
Isotype
IgG
Applications
Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), KnockDown
Conjugate
Biotin
Formulation
PBS with 0.05% Sodium Azide
Gene Alias
ARF, CDK4 inhibitor p16-INK4, CDK4IP14ARF, CDKN2, cell cycle negative regulator beta, CMM2P16-INK4A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLMP16INK4, MTS-1, MTS1P14, Multiple tumor suppressor 1, p14, p14ARF, P16, p16-INK4, p16-INK4a, P16INK4A, P19, p19Arf, TP16
Host Species
Rabbit
Purification Method
Affinity Purified
Regulatory Status
RUO
Primary or Secondary
Primary
Test Specificity
NB 200-111 reacts with human p14 ARF.
Content And Storage
Store at 4C in the dark.
Related Products
Description
- Description p14ARF/CDKN2A Polyclonal specifically detects p14ARF/CDKN2A in Human, Mouse samples
- It is validated for Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, Knockdown Validated.
Compare Similar Items
Show Difference
Antigen: p14ARF/CDKN2A
Classification: Polyclonal
Dilution: Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, KnockDown Validated
Gene Accession No.: Q8N726
Gene Symbols: CDKN2A
Immunogen: A synthetic peptide made to a portion of human p14ARF (between residues 50-150). [Swiss-Prot# Q8N726]
Quantity: 0.1 mL
Research Discipline: ABC Transporters, Cancer, Cell Biology, Cell Cycle and Replication, Chromatin Research, DNA Repair, Hypoxia, MAP Kinase Signaling, Neuroscience, Transcription Factors and Regulators, Tumor Suppressors
Gene ID (Entrez): 1029
Target Species: Human, Mouse
Isotype: IgG
Applications: Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), KnockDown
Conjugate: Biotin
Formulation: PBS with 0.05% Sodium Azide
Gene Alias: ARF, CDK4 inhibitor p16-INK4, CDK4IP14ARF, CDKN2, cell cycle negative regulator beta, CMM2P16-INK4A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLMP16INK4, MTS-1, MTS1P14, Multiple tumor suppressor 1, p14, p14ARF, P16, p16-INK4, p16-INK4a, P16INK4A, P19, p19Arf, TP16
Host Species: Rabbit
Purification Method: Affinity Purified
Regulatory Status: RUO
Primary or Secondary: Primary
Test Specificity: NB 200-111 reacts with human p14 ARF.
Content And Storage: Store at 4C in the dark.
Antigen:
p14ARF/CDKN2A
Classification:
Polyclonal
Dilution:
Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, KnockDown Validated
Gene Accession No.:
Q8N726
Gene Symbols:
CDKN2A
Immunogen:
A synthetic peptide made to a portion of human p14ARF (between residues 50-150). [Swiss-Prot# Q8N726]
Quantity:
0.1 mL
Research Discipline:
ABC Transporters, Cancer, Cell Biology, Cell Cycle and Replication, Chromatin Research, DNA Repair, Hypoxia, MAP Kinase Signaling, Neuroscience, Transcription Factors and Regulators, Tumor Suppressors
Gene ID (Entrez):
1029
Target Species:
Human, Mouse
Isotype:
IgG
Applications:
Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), KnockDown
Conjugate:
Biotin
Formulation:
PBS with 0.05% Sodium Azide
Gene Alias:
ARF, CDK4 inhibitor p16-INK4, CDK4IP14ARF, CDKN2, cell cycle negative regulator beta, CMM2P16-INK4A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLMP16INK4, MTS-1, MTS1P14, Multiple tumor suppressor 1, p14, p14ARF, P16, p16-INK4, p16-INK4a, P16INK4A, P19, p19Arf, TP16
Host Species:
Rabbit
Purification Method:
Affinity Purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Test Specificity:
NB 200-111 reacts with human p14 ARF.
Content And Storage:
Store at 4C in the dark.
Antigen: p14ARF/CDKN2A
Classification: Polyclonal
Dilution: Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, KnockDown Validated
Gene Accession No.: Q8N726
Gene Symbols: CDKN2A
Immunogen: A synthetic peptide made to a portion of human p14ARF (between residues 50-150). [Swiss-Prot# Q8N726]
Quantity: 0.1 mL
Research Discipline: ABC Transporters, Cancer, Cell Biology, Cell Cycle and Replication, Chromatin Research, DNA Repair, Hypoxia, MAP Kinase Signaling, Neuroscience, Transcription Factors and Regulators, Tumor Suppressors
Gene ID (Entrez): 1029
Target Species: Human, Mouse
Isotype: IgG
Applications: Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), KnockDown
Conjugate: DyLight 488
Formulation: 50mM Sodium Borate with 0.05% Sodium Azide
Gene Alias: ARF, CDK4 inhibitor p16-INK4, CDK4IP14ARF, CDKN2, cell cycle negative regulator beta, CMM2P16-INK4A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLMP16INK4, MTS-1, MTS1P14, Multiple tumor suppressor 1, p14, p14ARF, P16, p16-INK4, p16-INK4a, P16INK4A, P19, p19Arf, TP16
Host Species: Rabbit
Purification Method: Affinity Purified
Regulatory Status: RUO
Primary or Secondary: Primary
Test Specificity: NB 200-111 reacts with human p14 ARF.
Content And Storage: Store at 4C in the dark.
Antigen:
p14ARF/CDKN2A
Classification:
Polyclonal
Dilution:
Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, KnockDown Validated
Gene Accession No.:
Q8N726
Gene Symbols:
CDKN2A
Immunogen:
A synthetic peptide made to a portion of human p14ARF (between residues 50-150). [Swiss-Prot# Q8N726]
Quantity:
0.1 mL
Research Discipline:
ABC Transporters, Cancer, Cell Biology, Cell Cycle and Replication, Chromatin Research, DNA Repair, Hypoxia, MAP Kinase Signaling, Neuroscience, Transcription Factors and Regulators, Tumor Suppressors
Gene ID (Entrez):
1029
Target Species:
Human, Mouse
Isotype:
IgG
Applications:
Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), KnockDown
Conjugate:
DyLight 488
Formulation:
50mM Sodium Borate with 0.05% Sodium Azide
Gene Alias:
ARF, CDK4 inhibitor p16-INK4, CDK4IP14ARF, CDKN2, cell cycle negative regulator beta, CMM2P16-INK4A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLMP16INK4, MTS-1, MTS1P14, Multiple tumor suppressor 1, p14, p14ARF, P16, p16-INK4, p16-INK4a, P16INK4A, P19, p19Arf, TP16
Host Species:
Rabbit
Purification Method:
Affinity Purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Test Specificity:
NB 200-111 reacts with human p14 ARF.
Content And Storage:
Store at 4C in the dark.
Antigen: p14ARF/CDKN2A
Classification: Polyclonal
Dilution: Western Blot, ELISA, Immunohistochemistry, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, KnockDown Validated
Gene Accession No.: Q8N726
Gene Symbols: CDKN2A
Immunogen: A synthetic peptide made to a portion of human p14ARF (between residues 50-150). [Swiss-Prot# Q8N726]
Quantity: 0.1 mL
Research Discipline: ABC Transporters, Cancer, Cell Biology, Cell Cycle and Replication, Chromatin Research, DNA Repair, Hypoxia, MAP Kinase Signaling, Neuroscience, Transcription Factors and Regulators, Tumor Suppressors
Gene ID (Entrez): 1029
Target Species: Human, Mouse
Isotype: IgG
Applications: Western Blot, ELISA, Immunohistochemistry, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), KnockDown
Conjugate: HRP
Formulation: PBS with No Preservative
Gene Alias: ARF, CDK4 inhibitor p16-INK4, CDK4IP14ARF, CDKN2, cell cycle negative regulator beta, CMM2P16-INK4A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLMP16INK4, MTS-1, MTS1P14, Multiple tumor suppressor 1, p14, p14ARF, P16, p16-INK4, p16-INK4a, P16INK4A, P19, p19Arf, TP16
Host Species: Rabbit
Purification Method: Affinity Purified
Regulatory Status: RUO
Primary or Secondary: Primary
Test Specificity: NB 200-111 reacts with human p14 ARF.
Content And Storage: Store at 4C in the dark.
Antigen:
p14ARF/CDKN2A
Classification:
Polyclonal
Dilution:
Western Blot, ELISA, Immunohistochemistry, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, KnockDown Validated
Gene Accession No.:
Q8N726
Gene Symbols:
CDKN2A
Immunogen:
A synthetic peptide made to a portion of human p14ARF (between residues 50-150). [Swiss-Prot# Q8N726]
Quantity:
0.1 mL
Research Discipline:
ABC Transporters, Cancer, Cell Biology, Cell Cycle and Replication, Chromatin Research, DNA Repair, Hypoxia, MAP Kinase Signaling, Neuroscience, Transcription Factors and Regulators, Tumor Suppressors
Gene ID (Entrez):
1029
Target Species:
Human, Mouse
Isotype:
IgG
Applications:
Western Blot, ELISA, Immunohistochemistry, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), KnockDown
Conjugate:
HRP
Formulation:
PBS with No Preservative
Gene Alias:
ARF, CDK4 inhibitor p16-INK4, CDK4IP14ARF, CDKN2, cell cycle negative regulator beta, CMM2P16-INK4A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLMP16INK4, MTS-1, MTS1P14, Multiple tumor suppressor 1, p14, p14ARF, P16, p16-INK4, p16-INK4a, P16INK4A, P19, p19Arf, TP16
Host Species:
Rabbit
Purification Method:
Affinity Purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Test Specificity:
NB 200-111 reacts with human p14 ARF.
Content And Storage:
Store at 4C in the dark.
Antigen: p14ARF/CDKN2A
Classification: Polyclonal
Dilution: Flow Cytometry, KnockDown Validated
Gene Accession No.: Q8N726
Gene Symbols: CDKN2A
Immunogen: A synthetic peptide made to a portion of human p14ARF (between residues 50-150). [Swiss-Prot# Q8N726]
Quantity: 0.1 mL
Research Discipline: ABC Transporters, Cancer, Cell Biology, Cell Cycle and Replication, Chromatin Research, DNA Repair, Hypoxia, MAP Kinase Signaling, Neuroscience, Transcription Factors and Regulators, Tumor Suppressors
Gene ID (Entrez): 1029
Target Species: Human, Mouse
Isotype: IgG
Applications: Flow Cytometry, KnockDown
Conjugate: PE
Formulation: PBS with 0.05% Sodium Azide
Gene Alias: ARF, CDK4 inhibitor p16-INK4, CDK4IP14ARF, CDKN2, cell cycle negative regulator beta, CMM2P16-INK4A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLMP16INK4, MTS-1, MTS1P14, Multiple tumor suppressor 1, p14, p14ARF, P16, p16-INK4, p16-INK4a, P16INK4A, P19, p19Arf, TP16
Host Species: Rabbit
Purification Method: Affinity Purified
Regulatory Status: RUO
Primary or Secondary: Primary
Test Specificity: NB 200-111 reacts with human p14 ARF.
Content And Storage: Store at 4C in the dark.
Antigen:
p14ARF/CDKN2A
Classification:
Polyclonal
Dilution:
Flow Cytometry, KnockDown Validated
Gene Accession No.:
Q8N726
Gene Symbols:
CDKN2A
Immunogen:
A synthetic peptide made to a portion of human p14ARF (between residues 50-150). [Swiss-Prot# Q8N726]
Quantity:
0.1 mL
Research Discipline:
ABC Transporters, Cancer, Cell Biology, Cell Cycle and Replication, Chromatin Research, DNA Repair, Hypoxia, MAP Kinase Signaling, Neuroscience, Transcription Factors and Regulators, Tumor Suppressors
Gene ID (Entrez):
1029
Target Species:
Human, Mouse
Isotype:
IgG
Applications:
Flow Cytometry, KnockDown
Conjugate:
PE
Formulation:
PBS with 0.05% Sodium Azide
Gene Alias:
ARF, CDK4 inhibitor p16-INK4, CDK4IP14ARF, CDKN2, cell cycle negative regulator beta, CMM2P16-INK4A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLMP16INK4, MTS-1, MTS1P14, Multiple tumor suppressor 1, p14, p14ARF, P16, p16-INK4, p16-INK4a, P16INK4A, P19, p19Arf, TP16
Host Species:
Rabbit
Purification Method:
Affinity Purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Test Specificity:
NB 200-111 reacts with human p14 ARF.
Content And Storage:
Store at 4C in the dark.